Target intelligence / Profile preview

Immunoglobulin kappa variable 2D-26 (IGKV2D-26)

Target
IGKV2D-26
Molecular classification
Other (Immunoglobulin variable region pseudogene)
01

Overview

Immunoglobulin kappa variable 2D-26 (IGKV2D-26) is a human pseudogene belonging to the kappa light chain variable region gene family of immunoglobulins. It encodes the V (variable) domain of immunoglobulin light chains, which are essential for antigen recognition in functional immunoglobulins. However, IGKV2D-26 itself is annotated as a pseudogene, meaning it does not produce a functional protein. The immunoglobulin variable region genes, when functional, mediate antigen binding as part of the body's humoral immune response, but IGKV2D-26 does not encode a functional antibody chain and is not known to have therapeutic or biomarker relevance[1][2][5]. Clarification: IGKV2D-26 is a pseudogene—not a functional receptor, enzyme, transporter, or common therapeutic target. Its classification as a pseudogene means it does not encode a functional protein product and therefore is not druggable or directly linked to disease mechanisms, drug interactions, or safety concerns[1][2][5].

Other names
IGKV2D-26A5IGKV2D26Immunoglobulin kappa variable 2D-26immunoglobulin light chain variable region
02

Mechanism of action

None

03

Biological functions

None (pseudogene, no known function)
04

Disease associations

None (no direct involvement in disease, not a known disease gene)

Beyond the preview

Go deeper on Immunoglobulin kappa variable 2D-26 (IGKV2D-26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable 2D-26 (IGKV2D-26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call